Metformin may reduce the risk of cancer in patients with type 2 diabetes mellitus

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1491, 2005-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A diet high in low-fat dairy products may reduce the risk of developing type 2 diabetes mellitus in men

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus

By Howlett H.C.S.

Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. : 489-503

Adis International

Access to resources Recommend Favorite

Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus

By Chwieduk Claudine M.

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 349-361

Adis International

Access to resources Recommend Favorite

Metformin does not increase in-hospital mortality, and appears to reduce morbidity for patients with type 2 diabetes mellitus undergoing heart surgery

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Thiazolidinediones may double the risk of heart failure (HF) among patients receiving such drugs for type 2 diabetes mellitus

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite